Corporate Governance

3xl
right-aligned
white
white
Corporate Governance

We chose to report against the 2018 UK Corporate Governance Code (the “Code”) and this report sets out in broad terms how we have complied with the Code as of 30th June 2025.

A full version of the Code is available from the Financial Reporting Council website.

white
Our Committees
Audit Committee

Joanne Shaw chairs the Audit Committee. Its other members are Deborah Kemp, David Wilton, and Richard Gray. All members are fully independent. Joanne has a wealth of experience in senior finance roles within the Healthcare sector. The Board considers that members of the Audit Committee have recent and relevant financial expertise, and that the Committee as a whole has competence relevant to the sector in which the Company operates.

The Audit Committee’s duties primarily concern financial reporting, internal control and risk management systems, whistleblowing procedures and internal audit and external audit arrangements (including auditor independence).

Audit and Risk Committee

Joanne Shaw chairs the Audit and Risk Committee. Its other members are Deborah Kemp, David Wilton, and Richard Gray. All members are fully independent. Joanne has a wealth of experience in senior finance roles within the Healthcare sector. The Board considers that members of the Audit and Risk Committee have recent and relevant financial expertise, and that the Committee as a whole has competence relevant to the sector in which the Company operates.

The Audit and Risk Committee’s duties primarily concern financial reporting, internal control and risk management systems, whistleblowing procedures and internal audit and external audit arrangements (including auditor independence).

Remuneration Committee

Deborah Kemp chairs the Remuneration Committee. It’s other members are David Wilton, Joanne Shaw and Richard Gray. All members are fully independent.

The Remuneration Committee has delegated responsibility for designing and determining remuneration for the Chair, the Executive Directors and the next level of senior management, as well as the Company Secretary.

Nomination Committee

Richard Gray chairs the Nomination Committee. Its other members are David Wilton, Deborah Kemp and Joanne Shaw. All members are fully independent.

The Nomination Committee is responsible for reviewing the structure, size and composition, including skills, independence, knowledge and experience, of the Board. It is also responsible for the co-ordination of the annual evaluation of the performance of the Board and of its Committees, and for ensuring appropriate succession plans are in place. Given the size of the Group and the Company’s AIM listing, the Board does not believe external evaluation of the Board to be appropriate. All Directors engage in the internal evaluation and appropriate action is taken in light of the assessment. The Committee is responsible for making recommendations to the Board on all Board appointments and on the succession plans for both Executive Directors and Non-Executive Directors.

AIM Rule 26
All AIM-listed companies must have a website publicly available that includes information about the business including its location.
/investor-centre/aim-rule-26-compliance/
See our Aim Rule 26 Compliance
left
Tax Strategy
Find out more about the tax strategy of CVS Group plc and its wholly owned subsidiaries (“CVS” or “the Group”) in the UK, and other territories as applicable.
/investor-centre/tax-strategy-statement/
See our Tax Strategy
left
white